Objective: We aimed to investigate left atrium (LA) function by speckle tracking echocardiography in women with metabolic syndrome (MetSyn) admitted in chest pain unity with normal coronary angiography and to show a possible relationship between the severity of MetSyn and LA function Methods: we included 180 MetSyn patients without diabetes and 50 controls. The patients were classified into three groups based on the number of MetSyn criteria. The peak LA strain at the end of the ventricular systole (LAsstrain) as well as the LA strain with LA contraction (LAa-strain) was obtained. Correlation analysis performed to assess the association of LA strain parameters with the severity of MetSyn and logistic regression analysis performed to assess the relationship of low LA strain with MetSynd Purpose: Pulmonary artery (PA) dilatation is often seen in patients with pulmonary hypertension (PH). The objective of our study was to identify factors associated with PA dilatation and to assess its prognosis significance in group 1 and 4 PH patients.
Methods: Single arm, prospective study, from July 2012 to March 2014. Echocardiography was performed preoperatively, at discharge and at onemonth follow up. Inclusion criteria: 1/ Severe symptomatic aortic stenosis 2/ tricuspid aortic valve.Endpoints:1/ In hospital mortality 2/ Evolution of LVEF, IVSd and LVPWd 3/ Evolution of LV mass index 4/ Evolution of mean gradient and iEOA 5/Incidence of periprosthetic regurgitation (PPR) Results: 72 patients,age = 77.4±6.6,BMI = 31.2±4.2,Euroscore II= 3.4±3.4,LVEF = 63.4±10.2%,Aortic valve area = 0.5±0.2 cm²,Mean gradient = 56.7±19.3mmHg,Stroke volume = 49.9±11.6mL/m²,full sternotomy in all, associated CABG in 23 patients (33%), Cross clamping time = 48.7±22.3. 1/ In-hospital mortality: 1.4%. 2/ Evolution of LV parameters: LVEF(%) remains stable (61.6±8.9 versus 61.8±7.5, p=0.08), IVSd(mm) and LVPWd (mm) significantly decreased ((13.5±2 vs 14.9±1.7, p<0 .001) and (12.5±1.5 vs 15.3±1.4, p< 0.001)). 3/ Evolution of LV mass index: LV mass index (mg/m²) significantly decreased at one month FU(124.4±26.7 vs 167±45.1, p<0.001) 4/ Evolution of mean gradient and iEOA: Mean gradient (mmHg): 12.3±7.10 vs 56.7±19.3, p< 0.001 iEOA(cm²/m²): 1±0.4 vs 0.5±0.2, p<0.001 5/ Incidence of PPR No moderate or severe paravalvular leakage was observed at discharge and at follow-up.
Conclusions:
Edwards's Intuity bioprosthesis provides favorable preliminary results and is associated with significant regression of LV mass during the first month after aortic valve replacement.Midterm results should be evaluated.
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Prognosis value of main pulmonary artery dilatation in pulmonary hypertension Nathaniel Bitton (1), Olivier Chiche (1), Pamela Moceri (1), Pierre Cerboni (1), Sylvie Leroy (2), Delphine Baudouy (1), Emile Ferrari (1) (1) CHU Nice, Hôpital Pasteur, Cardiologie, Nice, CHU Nice, Pneumologie, Nice, France Purpose: Pulmonary artery (PA) dilatation is often seen in patients with pulmonary hypertension (PH). The objective of our study was to identify factors associated with PA dilatation and to assess its prognosis significance in group 1 and 4 PH patients.
Methods:
We performed a longitudinal cohort study, including consecutive patients with group 1 and 4 PH hospitalized in our center. All patients underwent clinical and biological evaluation, transthoracic echocardiography (TTE), CT scan and right heart catheterization and were followed every 3 months.
Results: 70 patients were recruited (70% group 1, 30% group 4). Mean age was 67±15 years and 70% were in functional class NYHA III or IV. PA dilatation (>30mm on CT) was observed in 87% of patients. Mean PA diameter was 37.2± 8.2mm and it was significantly larger in congenital heart disease patients: 46.2±8.6mm (p= 0.01). In multiple regression analysis, duration of symptoms (p= 0.01) and myocardial performance index (p= 0.02) were correlated with PA diameter. During a mean follow up of 59±19 months, 18 patients died (26%) (16 from heart failure and 2 from sudden death). On univariate analysis , while NYHA class (HR 2.37, 1.18-4.75), low 6-minute walk distance (HR 0.99 per 50m, 0.98-0.99), low cardiac index (HR 0.25 per 1L/min/m 2 , 0.09-0.71), right atrial pressure (HR 1.12 per 1 mmHg, 1.02-1.2), low TAPSE (HR 0.84 per 1mm, 0.76-0.93), right atrial area (HR 1.08 per 1cm 2 ,1.03-0.12) and high BNP were associated with mortality, PA diameter was not (HR: 0.97 per 1mm, 0.91-1.04). On multivariate analysis low TAPSE and high BNP level were independent predictors of all-cause mortality (respectively HR 0.72, 0.52-0.98 and 3.0, 1.01-8.90).
Conclusion:
PA dilatation is frequent in PH and is associated with the duration of symptoms and poor myocardial performance index. However, in group 1 and 4 PH patients, PA dilatation is not predictor of mortality.
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Variability of right ventricular strain derived from speckle-tracking analysis using two different software solutions Priscille Bouvier, Elie Dan Schouver, Nathaniel Bitton, Delphine Baudouy, Pierre Gibelin, Olivier Chiche, Pierre Cerboni, Emile Ferrari, Pamela Moceri CHU Nice, Hôpital Pasteur, Cardiologie, Nice, France Introduction: Speckle tracking imaging is a recent technique that can be achieved using either vendor dependent or vendor-independent software. Right ventricular (RV) strain is increasingly used as a prognostic tool in both left and right ventricular diseases. Only little is known regarding the variability of vendor-dependent and -independent speckle-tracking imaging software in the assessment of RV free wall longitudinal strain (RLS). The aim of our study was to compare a vendor-dependent (Qlab 9.0, Philips Medical System, Andover, MA, USA) and -independent (Cardiac Performance Analysis, Tomtec Imaging Systems, Germany) software for RLS analysis.
Methods and Results:
We prospectively enrolled 90 consecutive patients with pulmonary hypertension (mean age 55,8±19years) and 26 control patients (mean age 33,9±13years) who underwent a comprehensive echocardiogram including a RV focused 4-chamber view optimised for speckle-tracking analysis. DICOM data sets were stored and analysed by 2 different cardiologists using Qlab and TomTec, blindly to the context and each other. In the whole population, mean RLS was -17,3%±9 and -8,6% ±7,2 respectively using Qlab and Tomtec. Qlab and Tomtec intra-observer coefficients of variation (CV) were -13,19% and -9,56% and interobserver CVs were -22% and -15% respectively. The concordance correlation coefficient was 0,55, indicating poor agreement between the two methods. In the control population, Qlab CV was -3,63%, whereas CV was -17,8% in RV disease patients.
Conclusion:
Despite an acceptable level of variability for both techniques, Tomtec appears less variable. Variability of Qlab is excellent in control patients but is highly influenced by RV morphology. The agreement between the two software products is low and should lead in clinical practice to the follow-up of patients with the same software and advocates for the development of dedicated RV speckle-tracking software products.
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Significance of different ECG indices for left ventricular enlargement assessment: a cardiac MRI study Adrien Grandjean (1), Pierre-Yves Courand (1), Paul Charles (1), Vinciane Paget (2), Brahim Harbaoui (1), Fouad Khettab (2), Giampiero Bricca (3), Loic Boussel (4), Pierre Lantelme (1) (1) Hôpital de la Cardiologie, Lyon, Cardiologie, Villefranche Sur Saône, Objectives: Numerous ECG indices have been developed to diagnose left ventricular (LV) hypertrophy but ECG indexes assessing LV enlargement are lacking. The aim of the present study was to address the capacity of different ECG parameters to predict LV enlargement in different conditions, including myocardial infarction (MI), using cardiac MRI (CMR).
Designs and methods:
In a cohort of 501 patients with various clinical conditions, CMR and ECG were performed within a median period of 5 days. LV enlargement was defined by a LV end-diastolic volume indexed to body surface area (LVEDVI) >92mL/m 2 .
Results:
In the whole cohort, amplitudes of RaVL, SV3, SV1 and QRS duration correlated in univariate analysis with LVEDVI (R=0.108, 0.304, 0161 and 0.256 respectively, p<0.01 for all). In multivariable analysis (adjusted for age, BMI, LV mass index, systolic blood pressure and gender), only QRS duration and SV3 remained associated with LVEDVI (β=0.130, p<0.001; β=0.057, p<0.001, respectively). Areas under ROC curves (AUC) demonstrate that SV3 had the best performance to predict LV enlargement (AUC 0.701, specificity 96.9%, sensitivity 19.1%, optimal threshold 2.2mV, see figure) . In patients without MI (N=300), SV3 and QRS duration were independently correlated with LEVDVI (β=0.051, p<0.001; β=0.273, p<0.001, respectively), while in patient with MI only SV3 remained independently correlated with LEVDVI (β=0.051, p<0.001). AUC for SV3 were lower in patients with MI than those without (0.681 vs. 0.708), in women than in men (0.673 vs. 0.706) and in patients with QRS duration <120ms than those without (0.685 vs. 0.787). The optimal threshold of SV3 varies from 1.7 to 2.2mV according to different subgroups of patients.
